Drug-induced thrombocytopenia in children

Jessica A. Reese, Loan P. Nguyen, George R. Buchanan, Brian R. Curtis, Deirdra R. Terrell, Sara K. Vesely, James N. George

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Acute, immune-mediated thrombocytopenia may be caused by many different approved drugs as well as by other substances including vaccines, complementary and alternative medicines, herbal remedies, nutritional supplements, foods and beverages. All causes are described as drug-induced thrombocytopenia (DITP). Often the cause is not recognized, resulting in recurrent thrombocytopenia and inappropriate treatments. Systematic analysis of children (age less than 18 years) with suspected DITP has not been previously reported. Procedures: (1) We searched 15 databases to identify articles describing children with thrombocytopenia as an adverse effect of drugs and other substances. Articles were reviewed to assign levels of evidence for an association of the suspected substance with thrombocytopenia. (2) Data from the BloodCenter of Wisconsin were reviewed to identify reports of drug-dependent, platelet-reactive antibodies in children with suspected DITP. Results: Of 2,191 articles identified, 242 were selected for review. Seventy-two articles reporting 74 individual patients and nine groups of patients had evaluable data. Eleven individual patients and one group had definite evidence and 40 patients and three groups had probable evidence for an association of the suspected substance with thrombocytopenia. Thirty-two substances had a definite or probable association with thrombocytopenia. During 2008-2012, sera from 91 children with suspected DITP were tested and 21 had drug-dependent, platelet-reactive antibodies involving six substances. Conclusions: Drugs and other substances must be considered as potential causes of thrombocytopenia. Evidence from published reports and data for drug-dependent, platelet-reactive antibodies can help clinicians evaluate of children with unexpected thrombocytopenia. Pediatr Blood Cancer 2013;60:1975-1981.

Original languageEnglish (US)
Pages (from-to)1975-1981
Number of pages7
JournalPediatric Blood and Cancer
Volume60
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Thrombocytopenia
Pharmaceutical Preparations
Blood Platelets
Complementary Therapies
Antibodies
Food and Beverages
Idiopathic Thrombocytopenic Purpura
Vaccines
Databases

Keywords

  • Drug-induced thrombocytopenia (DITP)

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Reese, J. A., Nguyen, L. P., Buchanan, G. R., Curtis, B. R., Terrell, D. R., Vesely, S. K., & George, J. N. (2013). Drug-induced thrombocytopenia in children. Pediatric Blood and Cancer, 60(12), 1975-1981. https://doi.org/10.1002/pbc.24682

Drug-induced thrombocytopenia in children. / Reese, Jessica A.; Nguyen, Loan P.; Buchanan, George R.; Curtis, Brian R.; Terrell, Deirdra R.; Vesely, Sara K.; George, James N.

In: Pediatric Blood and Cancer, Vol. 60, No. 12, 12.2013, p. 1975-1981.

Research output: Contribution to journalArticle

Reese, JA, Nguyen, LP, Buchanan, GR, Curtis, BR, Terrell, DR, Vesely, SK & George, JN 2013, 'Drug-induced thrombocytopenia in children', Pediatric Blood and Cancer, vol. 60, no. 12, pp. 1975-1981. https://doi.org/10.1002/pbc.24682
Reese JA, Nguyen LP, Buchanan GR, Curtis BR, Terrell DR, Vesely SK et al. Drug-induced thrombocytopenia in children. Pediatric Blood and Cancer. 2013 Dec;60(12):1975-1981. https://doi.org/10.1002/pbc.24682
Reese, Jessica A. ; Nguyen, Loan P. ; Buchanan, George R. ; Curtis, Brian R. ; Terrell, Deirdra R. ; Vesely, Sara K. ; George, James N. / Drug-induced thrombocytopenia in children. In: Pediatric Blood and Cancer. 2013 ; Vol. 60, No. 12. pp. 1975-1981.
@article{55eb2eb31a5f42f4ab0c6d1668fce139,
title = "Drug-induced thrombocytopenia in children",
abstract = "Background: Acute, immune-mediated thrombocytopenia may be caused by many different approved drugs as well as by other substances including vaccines, complementary and alternative medicines, herbal remedies, nutritional supplements, foods and beverages. All causes are described as drug-induced thrombocytopenia (DITP). Often the cause is not recognized, resulting in recurrent thrombocytopenia and inappropriate treatments. Systematic analysis of children (age less than 18 years) with suspected DITP has not been previously reported. Procedures: (1) We searched 15 databases to identify articles describing children with thrombocytopenia as an adverse effect of drugs and other substances. Articles were reviewed to assign levels of evidence for an association of the suspected substance with thrombocytopenia. (2) Data from the BloodCenter of Wisconsin were reviewed to identify reports of drug-dependent, platelet-reactive antibodies in children with suspected DITP. Results: Of 2,191 articles identified, 242 were selected for review. Seventy-two articles reporting 74 individual patients and nine groups of patients had evaluable data. Eleven individual patients and one group had definite evidence and 40 patients and three groups had probable evidence for an association of the suspected substance with thrombocytopenia. Thirty-two substances had a definite or probable association with thrombocytopenia. During 2008-2012, sera from 91 children with suspected DITP were tested and 21 had drug-dependent, platelet-reactive antibodies involving six substances. Conclusions: Drugs and other substances must be considered as potential causes of thrombocytopenia. Evidence from published reports and data for drug-dependent, platelet-reactive antibodies can help clinicians evaluate of children with unexpected thrombocytopenia. Pediatr Blood Cancer 2013;60:1975-1981.",
keywords = "Drug-induced thrombocytopenia (DITP)",
author = "Reese, {Jessica A.} and Nguyen, {Loan P.} and Buchanan, {George R.} and Curtis, {Brian R.} and Terrell, {Deirdra R.} and Vesely, {Sara K.} and George, {James N.}",
year = "2013",
month = "12",
doi = "10.1002/pbc.24682",
language = "English (US)",
volume = "60",
pages = "1975--1981",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Drug-induced thrombocytopenia in children

AU - Reese, Jessica A.

AU - Nguyen, Loan P.

AU - Buchanan, George R.

AU - Curtis, Brian R.

AU - Terrell, Deirdra R.

AU - Vesely, Sara K.

AU - George, James N.

PY - 2013/12

Y1 - 2013/12

N2 - Background: Acute, immune-mediated thrombocytopenia may be caused by many different approved drugs as well as by other substances including vaccines, complementary and alternative medicines, herbal remedies, nutritional supplements, foods and beverages. All causes are described as drug-induced thrombocytopenia (DITP). Often the cause is not recognized, resulting in recurrent thrombocytopenia and inappropriate treatments. Systematic analysis of children (age less than 18 years) with suspected DITP has not been previously reported. Procedures: (1) We searched 15 databases to identify articles describing children with thrombocytopenia as an adverse effect of drugs and other substances. Articles were reviewed to assign levels of evidence for an association of the suspected substance with thrombocytopenia. (2) Data from the BloodCenter of Wisconsin were reviewed to identify reports of drug-dependent, platelet-reactive antibodies in children with suspected DITP. Results: Of 2,191 articles identified, 242 were selected for review. Seventy-two articles reporting 74 individual patients and nine groups of patients had evaluable data. Eleven individual patients and one group had definite evidence and 40 patients and three groups had probable evidence for an association of the suspected substance with thrombocytopenia. Thirty-two substances had a definite or probable association with thrombocytopenia. During 2008-2012, sera from 91 children with suspected DITP were tested and 21 had drug-dependent, platelet-reactive antibodies involving six substances. Conclusions: Drugs and other substances must be considered as potential causes of thrombocytopenia. Evidence from published reports and data for drug-dependent, platelet-reactive antibodies can help clinicians evaluate of children with unexpected thrombocytopenia. Pediatr Blood Cancer 2013;60:1975-1981.

AB - Background: Acute, immune-mediated thrombocytopenia may be caused by many different approved drugs as well as by other substances including vaccines, complementary and alternative medicines, herbal remedies, nutritional supplements, foods and beverages. All causes are described as drug-induced thrombocytopenia (DITP). Often the cause is not recognized, resulting in recurrent thrombocytopenia and inappropriate treatments. Systematic analysis of children (age less than 18 years) with suspected DITP has not been previously reported. Procedures: (1) We searched 15 databases to identify articles describing children with thrombocytopenia as an adverse effect of drugs and other substances. Articles were reviewed to assign levels of evidence for an association of the suspected substance with thrombocytopenia. (2) Data from the BloodCenter of Wisconsin were reviewed to identify reports of drug-dependent, platelet-reactive antibodies in children with suspected DITP. Results: Of 2,191 articles identified, 242 were selected for review. Seventy-two articles reporting 74 individual patients and nine groups of patients had evaluable data. Eleven individual patients and one group had definite evidence and 40 patients and three groups had probable evidence for an association of the suspected substance with thrombocytopenia. Thirty-two substances had a definite or probable association with thrombocytopenia. During 2008-2012, sera from 91 children with suspected DITP were tested and 21 had drug-dependent, platelet-reactive antibodies involving six substances. Conclusions: Drugs and other substances must be considered as potential causes of thrombocytopenia. Evidence from published reports and data for drug-dependent, platelet-reactive antibodies can help clinicians evaluate of children with unexpected thrombocytopenia. Pediatr Blood Cancer 2013;60:1975-1981.

KW - Drug-induced thrombocytopenia (DITP)

UR - http://www.scopus.com/inward/record.url?scp=84885800210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885800210&partnerID=8YFLogxK

U2 - 10.1002/pbc.24682

DO - 10.1002/pbc.24682

M3 - Article

C2 - 24038783

AN - SCOPUS:84885800210

VL - 60

SP - 1975

EP - 1981

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 12

ER -